Clinical samples and GSC cell-lines expressing the methylated MGMT gene promoter were used to evaluate the effects of Tf-targeted nanoparticles pre-loaded with TMZ with the aim of damaging GSCs and inhibiting regrowth of GBM orthotopic xenografts. Here, MGMT is linked to glioblastoma.